azelnidipine has been researched along with Brain Ischemia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Mudhafar, A; Fakharaldeen, Z; Hadi, N; Radhi, A | 1 |
| Abe, K; Deguchi, K; Kamiya, T; Lukic-Panin, V; Sehara, Y; Yamashita, T; Zhang, H | 1 |
| Hatazawa, J; Hougaku, H; Kajimoto, K; Kato, H; Kimura, Y; Kitagawa, K; Oku, N; Sakaguchi, M; Sakoda, S; Tanaka, M | 1 |
| Abe, K; Deguchi, K; Kamiya, T; Nagotani, S; Yamashita, T | 1 |
| Hirano, T; Okamoto, S; Shiraishi, S; Tomiguchi, S; Uchino, M; Watanabe, M | 1 |
| Chen, R; Horiuchi, M; Ide, A; Iwai, M; Iwanami, J; Mogi, M; Tomochika, H; Tomono, Y | 1 |
1 review(s) available for azelnidipine and Brain Ischemia
| Article | Year |
|---|---|
Gene and stem cell therapy in ischemic stroke.
Topics: Animals; Antioxidants; Azetidinecarboxylic Acid; Biliverdine; Brain Ischemia; Dihydropyridines; Disease Models, Animal; Genetic Therapy; Glial Cell Line-Derived Neurotrophic Factor; Humans; Models, Biological; Neuroprotective Agents; Stem Cell Transplantation | 2009 |
2 trial(s) available for azelnidipine and Brain Ischemia
| Article | Year |
|---|---|
Hemodynamic influences of azelnidipine, a novel calcium channel blocker, on cerebral circulation in hypertensive patients with ischemic white matter lesions.
Topics: Acetazolamide; Aged; Aged, 80 and over; Azetidinecarboxylic Acid; Blood Pressure; Brain Ischemia; Calcium Channel Blockers; Cerebrovascular Circulation; Dihydropyridines; Diuretics; Female; Humans; Hypertension; Male; Middle Aged; Positron-Emission Tomography; Regional Blood Flow | 2008 |
Azelnidipine, a long-acting calcium channel blocker, could control hypertension without decreasing cerebral blood flow in post-ischemic stroke patients. A 123I-IMP SPECT follow-up study.
Topics: Aged; Azetidinecarboxylic Acid; Blood Pressure; Brain Ischemia; Calcium Channel Blockers; Cerebral Infarction; Cerebrovascular Circulation; Dihydropyridines; Female; Follow-Up Studies; Functional Laterality; Heart Rate; Humans; Hypertension; Image Processing, Computer-Assisted; Iofetamine; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Stroke; Tomography, Emission-Computed, Single-Photon | 2010 |
3 other study(ies) available for azelnidipine and Brain Ischemia
| Article | Year |
|---|---|
Potential protective effects of Azelnidipine against cerebral ischemia-reperfusion injury in male rats.
Topics: Animals; Antioxidants; Brain Ischemia; Cerebral Infarction; Intercellular Adhesion Molecule-1; Interleukin-10; Interleukin-6; Male; NF-kappa B; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2022 |
Therapeutic strategy for ischemic stroke.
Topics: Animals; Azetidinecarboxylic Acid; Biliverdine; Brain Ischemia; Dihydropyridines; Free Radical Scavengers; Granulocyte Colony-Stimulating Factor; Neuroprotective Agents; Rats; Stem Cells; Stroke; Tissue Scaffolds | 2009 |
The calcium-channel blocker, azelnidipine, enhances the inhibitory action of AT1 receptor blockade on ischemic brain damage.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Azetidinecarboxylic Acid; Brain Ischemia; Calcium Channel Blockers; Cerebrovascular Circulation; Dihydropyridines; Disease Models, Animal; Drug Therapy, Combination; Imidazoles; Male; Mice; Mice, Inbred C57BL; Tetrazoles | 2006 |